New Drug Application News and Research

RSS
COVID-19 vaccine candidate shows potent immune response

COVID-19 vaccine candidate shows potent immune response

Investigational antidepressant PT150 shows antiviral activity against SARS-CoV-2

Investigational antidepressant PT150 shows antiviral activity against SARS-CoV-2

Researchers discover novel class of safer analgesics

Researchers discover novel class of safer analgesics

New vitamin K-based drug eliminates medication-resistant epileptic seizures in mice

New vitamin K-based drug eliminates medication-resistant epileptic seizures in mice

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

Octapharma extends support for COVID-19 study following promising preliminary data

Octapharma extends support for COVID-19 study following promising preliminary data

USAMRDC receives FDA marketing approval for severe malaria treatment

USAMRDC receives FDA marketing approval for severe malaria treatment

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Investigational oral form of treatment offers hope for adults with acromegaly

Investigational oral form of treatment offers hope for adults with acromegaly

FDA approves immune-modulating therapy for treatment of multiple sclerosis

FDA approves immune-modulating therapy for treatment of multiple sclerosis

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

Mayo Clinic researchers seek radical new approach to treat cocaine addition

Mayo Clinic researchers seek radical new approach to treat cocaine addition

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Failed cancer drug could potentially be used to treat fibrotic diseases and scleroderma

Failed cancer drug could potentially be used to treat fibrotic diseases and scleroderma

Many drug manufacturers fail to complete the FDA approval process, research reveals

Many drug manufacturers fail to complete the FDA approval process, research reveals

Finding innovative treatments to help patients with traumatic brain injury

Finding innovative treatments to help patients with traumatic brain injury

FDA clears its IND for new immunotherapeutic for treating prostate cancer

FDA clears its IND for new immunotherapeutic for treating prostate cancer